242 related articles for article (PubMed ID: 29086018)
21. Quality of life in adult patients with limb-girdle muscular dystrophies.
Peric M; Peric S; Stevanovic J; Milovanovic S; Basta I; Nikolic A; Kacar A; Rakocevic-Stojanovic V
Acta Neurol Belg; 2018 Jun; 118(2):243-250. PubMed ID: 29116571
[TBL] [Abstract][Full Text] [Related]
22. Chronic inflammatory demyelinating polyneurophaty: assessment of the cognitive function and quality of life.
Kozow L; Pupe C; Nascimento OJM
Arq Neuropsiquiatr; 2022 Dec; 80(12):1246-1253. PubMed ID: 36580963
[TBL] [Abstract][Full Text] [Related]
23. Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric S; Basta I; Rakocevic-Stojanovic V; Lavrnic D; Stevic Z; Radovanovic S
J Clin Neurosci; 2020 Oct; 80():6-10. PubMed ID: 33099368
[TBL] [Abstract][Full Text] [Related]
24. A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy.
Gable KL; Peric S; Lutz MW; Bozovic I; Petrovic M; Stojanov A; Basta I; Allen JA
Brain Behav; 2022 Aug; 12(8):e2712. PubMed ID: 35862228
[TBL] [Abstract][Full Text] [Related]
25. Impairment and disability in 20 CIDP patients according to disease activity status.
Panaite PA; Renaud S; Kraftsik R; Steck AJ; Kuntzer T
J Peripher Nerv Syst; 2013 Sep; 18(3):241-6. PubMed ID: 24028192
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK
Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110
[TBL] [Abstract][Full Text] [Related]
27. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
28. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Overgaard K; Jakobsen J
J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
[TBL] [Abstract][Full Text] [Related]
29. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
30. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group.
Merkies IS; Schmitz PI; Samijn JP; van der Meché FG; van Doorn PA
Neurology; 1999 Nov; 53(8):1648-54. PubMed ID: 10563607
[TBL] [Abstract][Full Text] [Related]
31. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
[TBL] [Abstract][Full Text] [Related]
32. Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases.
Boukhris S; Magy L; Gallouedec G; Khalil M; Couratier P; Gil J; Vallat JM
J Peripher Nerv Syst; 2005 Sep; 10(3):329-37. PubMed ID: 16221292
[TBL] [Abstract][Full Text] [Related]
33. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
[TBL] [Abstract][Full Text] [Related]
34. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B
Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683
[TBL] [Abstract][Full Text] [Related]
35. Economic costs and quality of life in chronic inflammatory neuropathies in southeast England.
Mahdi-Rogers M; McCrone P; Hughes RA
Eur J Neurol; 2014; 21(1):34-9. PubMed ID: 23930744
[TBL] [Abstract][Full Text] [Related]
36. Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Gorson KC; Cros D; Griffin J; Pollard J; Vallat JM; Maurer SL; Riester K; Davar G; Dawson K; Sandrock A;
Neurology; 2010 Feb; 74(8):651-7. PubMed ID: 20177118
[TBL] [Abstract][Full Text] [Related]
37. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
Reynolds J; Sachs G; Stavros K
R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
[TBL] [Abstract][Full Text] [Related]
38. Postural tremor and chronic inflammatory demyelinating polyneuropathy.
Cao Y; Menon P; Ching-Fen Chang F; Mahant N; Geevasinga N; Fung VS; Vucic S
Muscle Nerve; 2017 Mar; 55(3):338-343. PubMed ID: 27421831
[TBL] [Abstract][Full Text] [Related]
39. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance.
Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554
[TBL] [Abstract][Full Text] [Related]
40. Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.
Merkies IS; Schmitz PI
J Neurol Neurosurg Psychiatry; 2006 Aug; 77(8):970-2. PubMed ID: 16549419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
